UK: The European Patent Office Introduces A "Go-Faster" Opposition Process

The European Patent Office (EPO) has announced that from 1 July 2016, post-grant oppositions will be reformed so that they become significantly faster and more efficient.1 The effect of these changes is that in straightforward cases, the decision in a first instance opposition will be issued within 15 months of the close of the opposition period (which is nine months after the date the European patent was granted).

This is a significant acceleration of the previously notoriously slow opposition procedure. It will be of strategic importance to patentees and their competitors alike, especially against the background of the impending introduction of the Unified Patent Court, and the concerns expressed by national courts in Europe about the significant lack of commercial certainty imposed by the hitherto lengthy EPO opposition procedure.

  • The EPO's pre-July 2016 opposition procedure has been roundly criticised by courts across Europe for its lengthy and open-ended process. "Normal" cases take an average of between four to eight years through to final determination (including appeals). As most European countries stay national litigation pending resolution of an EPO opposition – including the key issue of infringement, which is the exclusive prerogative of the national courts, not the EPO – this can have a chilling effect on business.
  • These reforms demonstrate the EPO's wish to reconfigure its procedures preparatory to the introduction of the Unified Patent Court sometime in 2017, so that the EPO opposition timelines broadly conform with the UPC litigation ones.
  • Patent proprietors and their competitors should now be recalibrating their European patent litigation strategies, including in countries such as England and the Republic of Ireland that do not always stay national litigation pending the result of an EPO opposition. This truncated timeline offers significant strategic opportunities and threats, although it remains to be seen whether the EPO can deliver this faster opposition process, or how easily a determined party can derail it in practice. Nonetheless, these reforms show the EPO as being determined to offer a competing route to central revocation of a European patent, to that offered by the forthcoming Unified Patent Court.
  • While not in itself conclusive, this change in EPO opposition timelines will also change the balance of discretionary factors that the English courts consider when deciding whether or not to order a stay of English national litigation. Broadly, it will be likely to tip the balance towards the grant of a stay. This is because often the most compelling argument in favour of a stay is whether the EPO opposition will finish significantly earlier than, or not much later than, a national trial.

The commercial imperative – the need for certainty and speed Historically, the EPO opposition process is lengthy and drawn out with frequent delays. It can often take between four and eight years before the opposition procedure and all possible appeals are exhausted. The record currently stands at 14 years.2 Even if there is a successful request to accelerate the EPO opposition proceedings because there are pending patent infringement proceedings,3 it can still take up to three years for a final EPO decision (a wait of 15 to 24 months is typical).

The EPO's opposition process has been a victim of its own success. But its delays have attracted significant judicial criticism from national courts. In IPCOM GmbH & Co KG v. HTC Europe Co Limited4 – the leading English case on whether to grant a stay pending resolution of an EPO opposition – Lord Justice Floyd, in giving the unanimous Court of Appeal judgment, held that:

"A procedure which allows disputes over patent rights to take in excess of a decade cannot meet the needs of industry, particularly in rapidly moving areas of technology. Although such a procedure may technically comply with Article 6 of the European Convention on Human Rights, which guarantees a trial before an independent tribunal within a reasonable time, the opportunity for successive appeals and remittals means that there is in practice no final determination of the parties' rights for many years. Given their procedures, the Boards have a difficult task in seeking to achieve justice and finality."

A major concern about EPO oppositions is that while there are clear deadlines for beginning them (they must be launched within nine months of grant), there are no provisions regulating when they must end. One important reason for the drawn-out nature of oppositions is the EPO's serial approach to decision making. Where there are a variety of grounds of opposition, the EPO's practice is to decide the issues in a given order; if a ground succeeds, it is then rare for the Opposition Division (OD) to go on and decide all the other grounds of opposition, as is common in national courts. The inevitable consequence is further delay. If the OD's decision is overturned on appeal, the Technical Board of Appeal will normally have to remit the case back to the OD for it to consider the next issue in the sequence, and so on.

The slow speed of EPO oppositions is particularly troubling for the patentees of patents with shorter life spans. For example, the latest high-tech products are frequently overtaken by more sophisticated alternatives within a few years of appearing on the market, and the value of any corresponding patent rights may be equally short-lived.

The ability to clear the path of third-party rights, or to take swift enforcement action in the early life of a patent, may be critical in fast-moving and competitive industries. Delays of four to six years while the EPO decides whether a patent is valid are not commercially viable. For many companies, a swift decision by a national court may be preferable to achieve some degree of certainty in a key market. A slower but more cost-effective central attack at the EPO can be simultaneously pursued in the hope of achieving a pan-European decision at a later date.

The new procedure in more detail The EPO's streamlined new opposition procedure in effect from 1 July 2016, is intended to simplify opposition proceedings and deliver decisions faster. It is also intended to give the parties more time to react to the summons for oral proceedings, and to prepare for the full opposition hearing.

The principal features of the new procedure are as follows:

  • When filing their formal pleadings, both the opponent and the proprietor must file all relevant documents, even if available in the EPO documentation; translations of any documents not in an EPO official language; and, wherever possible, a copy of any further evidence indicated in them.
  • The parties are obliged to identify in their pleadings the facts, evidence, and arguments they propose to rely on in support of their assertions as to the grounds of opposition.
  • The proprietor's reply is due within four months, and must include any proposed amendments to the patent. The OD will immediately communicate these to the opponent on receipt.
  • The normal period for replying to communications from the OD is four months for communications raising matters of substance and two months for other communications. Extensions of time will only be granted in exceptional cases with duly substantiated requests.
  • If evidence is submitted out of time, the OD will ignore it unless it is of prima facie relevance, i.e., would affect the outcome of the decision to be taken.
  • If oral proceedings are requested by the parties or deemed expedient by the OD, then the date will be fixed when the summons is issued. This date will be not earlier than six months after the summons is sent. At the same time, the OD will set out the issues which it considers must be discussed at the oral proceedings, together with the OD's provisional and non-binding opinion on (i) the positions adopted by the parties, and in particular on (ii) any amendments filed by the proprietor.
  • While the topics dealt with at the oral proceedings are intended to be those specified in writing by the OD, it will not be confined to those issues alone, provided a party's submissions are relevant. But, importantly, if new facts or evidence are submitted for the first time at the oral proceedings, they will be regarded as late-filed and will only be considered if they are of prima facie relevance.

Comment This streamlined opposition procedure is intended to give legal certainty to the parties and the public in a timely and effective manner. While these changes are to be welcomed, it remains to be seen how in practice these reforms will play out and whether they will deliver on the promise of faster justice.

While the desire of the EPO to speed up the opposition procedure should be commended, it appears to be largely at the expense of the patent proprietors. The reduced time to a first instance decision appears in part to be being achieved by limiting the time available for patent proprietors to respond to the opposition. They previously had four months to reply to an opposition, with a two-month extension generally available upon request and additional further extensions often being granted; this will not be the case under the new procedure, where extensions to the initial four-month period will be available only "in exceptional cases with duly substantiated requests". Moreover, there is a notable distinction between the nine months an opponent has to prepare their opposition case and the now four months given to patent proprietors to marshal their fully reasoned and evidenced response to the opposition.

These changes only deal with the first instance part of the opposition process. To that extent, they leave untouched aspects of the overall opposition process which have significant potential to create delay. They do not affect the appeals procedure, which is still governed by the 2007 Rules of Procedure of the Boards of Appeal. Those rules, and the current state of appeal backlogs, mean that most appeal proceedings will continue to add another three or four years to the total opposition procedure time. Nor do they prima facie change the serial nature of EPO decision making, something identified by national courts as a serious cause of delay.

Footnotes

1 EPO Official Journal May 2016, Article A42, 31 May 2016

2 This was the opposition in the Hepatitis B virus litigation between Biogen Inc. and Medeva plc. The judge in the English part of this litigation characterised this delay as "disturbing".

3 See T290/90 SAVIO [1992] OJEPO 368.

4 IPCOM GmbH & Co KG v. HTC Europe Co Limited, Court of Appeal, [2013] EWCA Civ 1496.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions